Advertisement

Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

Horizon Pharma plc

Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing products to primary care, orthopedic surgeons and rheumatologists. The Company markets DUEXIS® and RAYOS®/LODOTRA® and will market VIMOVO®, which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire or in-license additional innovative medicines where it can execute a targeted commercial approach among specific target physicians while taking advantage of its commercial strengths and the infrastructure the Company has put in place. *

 

Period Start 2014-03-19 merged
  Group Horizon Therapeutics (Group)
  Today Horizon Therapeutics plc (Nasdaq: HZNP)
  Successor Horizon Therapeutics plc (Nasdaq: HZNP)
Product Industry pharmaceutical
Person Person Walbert, Timothy P. (Tim) (Horizon Pharma 201003– CEO before IDM Pharma CEO before NeoPharm + Abbott)
     
Region Region Dublin
  Country Ireland, Republic of
  Street Peter Street
Adelaide Chambers
  City Dublin 8
  Tel +353-1-649-8521
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: 
     
   
Record changed: 2020-01-27

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Horizon Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px




» top